Novel compositions and methods for the treatment of immune related diseases

Details for Australian Patent Application No. 2003267096 (hide)

Owner Genentech, Inc.

Inventors Jackman, Janet K.; Clark, Hilary; Williams, P. Mickey; Wu, Thomas D.; Hunte, Brisdell; Schoenfeld, Jill R.; Bodary, Sarah C.; Wood, William I.

Agent Griffith Hack

Pub. Number AU-B-2003267096

PCT Number PCT/US03/28361

PCT Pub. Number WO2004/024076

Priority 60/410,174 11.09.02 US

Filing date 10 September 2003

Wipo publication date 30 April 2004

Acceptance publication date 20 May 2010

International Classifications

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 31/409 (2006.01) - having four such rings, e.g. porphine derivatives, bilirubin, biliverdine

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 35/00 (2006.01) Antineoplastic agents

C07D 471/22 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C07K 14/00 (2006.01) Peptides having more than 20 amino acids

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

C07K 19/00 (2006.01) Hybrid peptides

C12N 1/15 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/19 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 15/00 (2006.01) Mutation or genetic engineering

C12N 15/12 (2006.01) Mutation or genetic engineering - Genes encoding animal proteins

C12N 15/63 (2006.01) Mutation or genetic engineering - Introduction of foreign genetic material using vectors

C12N 15/85 (2006.01) Mutation or genetic engineering - for animal cells

C12P 21/02 (2006.01) Preparation of peptides or proteins - having a known sequence of two or more amino acids, e.g. glutathione

C12Q 1/02 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving viable micro-organisms

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

Event Publications

8 January 2004 Complete Application Filed

  Priority application(s): 60/410,174 11.09.02 US

20 May 2004 Application Open to Public Inspection

  Published as AU-B-2003267096

20 May 2010 Application Accepted

  Published as AU-B-2003267096

23 September 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003267097-Novel composition and methods for the treatment of psoriasis

2003267095-System for efficient recovery of Node-B buffered data following MAC layer reset